HTG MOLECULAR DIAGNOSTICS, INC | Business Contracts

Form of Placement Agent Warrant, issued on December 23, 2022 (Filed With SEC on December 23, 2022)

Fourth Amendment, dated September 27, 2021, to Standard Commercial-Industrial Multi Tenant Triple Net Lease, dated May 11, 2011, between the Company and Pegasus Properties L.P (Filed With SEC on September 29, 2021)

HTG Molecular Diagnostics, Inc. Severance and Change in Control Plan (Filed With SEC on March 25, 2021)

Controlled Equity OfferingSM Sales Agreement, dated as of November 14, 2019, by and between HTG Molecular Diagnostics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 15, 2019)

Form of Pre-funded Warrant to Purchase Common Stock, issued on December 23, 2022 (Filed With SEC on December 23, 2022)

Form of Series A-2 Warrant to Purchase Common Stock, issued on December 23, 2022 (Filed With SEC on December 23, 2022)

Form of Series A-1 Warrant to Purchase Common Stock, issued on December 23, 2022 (Filed With SEC on December 23, 2022)

Form of Securities Purchase Agreement (Filed With SEC on December 21, 2022)

Form of Placement Agent Warrant (Filed With SEC on December 21, 2022)

Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on December 21, 2022)

Form of Series A-1 and Series A-2 Warrant to Purchase Common Stock (Filed With SEC on December 21, 2022)

Form of Common Stock Certificate of the Registrant (Filed With SEC on December 21, 2022)

Second Amendment to Loan and Security Agreement, dated September 8, 2022, by and between Silicon Valley Bank and the Company (Filed With SEC on November 10, 2022)

Purchase Agreement, dated October 21, 2022, by and between HTG Molecular Diagnostics, Inc. and the purchaser named therein (Filed With SEC on October 21, 2022)

First Amendment to Loan and Security Agreement, dated July 14, 2022, by and between Silicon Valley Bank and the Company (Filed With SEC on July 18, 2022)

Description of Common Stock (Filed With SEC on March 29, 2022)

Registration Rights Agreement, dated as of March 17, 2022, between HTG Molecular Diagnostics, Inc. and the purchaser party thereto (Filed With SEC on March 21, 2022)

Form of Common Stock Warrant (66-month term) (Filed With SEC on March 21, 2022)

Form of Common Stock Warrant (24-month term) (Filed With SEC on March 21, 2022)

Form of Pre-Funded Warrant (Filed With SEC on March 21, 2022)

Third Amendment, dated September 27, 2021, to Standard Commercial-Industrial Multi Tenant Triple Net Lease, dated July 11, 2008, between the Company and Pegasus Properties L.P (Filed With SEC on September 29, 2021)

HTG Molecular Diagnostics, Inc. Amended and Restated 2014 Employee Stock Purchase Plan (Filed With SEC on August 19, 2021)

Form of Common Stock Certificate of the Registrant (Filed With SEC on March 25, 2021)

Third Amendment to Lease Agreement (Suite 100 Administration), dated December 8, 2020, by and between the Registrant and Pegasus Properties, L.P (Filed With SEC on March 25, 2021)

Second Amendment to Lease Agreement (Suite 300 Laboratory), dated December 8, 2020, by and between the Registrant and Pegasus Properties, L.P (Filed With SEC on March 25, 2021)

HTG Molecular Diagnostics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 25, 2021)

Description of Capital Stock (Filed With SEC on March 25, 2021)

HTG Molecular Diagnostics, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 20, 2020)

Loan and Security Agreement, dated June 24, 2020, by and among the Company and Silicon Valley Bank (Filed With SEC on June 25, 2020)

Warrant to Purchase Common Stock, issued to Silicon Valley Bank on June 24, 2020 (Filed With SEC on June 25, 2020)

Registration Rights Agreement, dated as of March 24, 2020, by and between the Company and Lincoln Park (Filed With SEC on March 25, 2020)

Purchase Agreement, dated as of March 24, 2020, by and between the Company and Lincoln Park (Filed With SEC on March 25, 2020)

Employment Agreement, dated July 28, 2019, by and between Byron Lawson and the Registrant (Filed With SEC on March 25, 2020)

Amendment No. 2 to Credit and Security Agreement (Revolving Loan) by and among the Registrant, the lenders party thereto from time to time and MidCap Funding IV Trust (assignee of... (Filed With SEC on March 25, 2020)

Amendment No. 1 to Credit and Security Agreement (Revolving Loan) by and among the Registrant, the lenders party thereto from time to time and MidCap Funding IV Trust (assignee of... (Filed With SEC on March 25, 2020)

Amendment No. 1 to Credit and Security Agreement (Term Loan) by and among the Registrant, the lenders party thereto from time to time and MidCap Financial Trust, as agent, dated... (Filed With SEC on March 25, 2020)

Description of Capital Stock (Filed With SEC on March 25, 2020)

Amendment No. 3 to Credit and Security Agreement (Revolving Loan), dated February 26, 2020, by and among the Company, the lenders party thereto and MidCap Funding IV Trust, as... (Filed With SEC on February 27, 2020)

Amendment No. 2 to Credit and Security Agreement (Term Loan), dated February 26, 2020, by and among the Company, the lenders party thereto and MidCap Financial Trust, as agent (Filed With SEC on February 27, 2020)

Amended and Restated Non-employee Director Compensation Policy (Filed With SEC on November 12, 2019)

Employment Agreement, dated July 28, 2019, by and between Shaun D. McMeans and the Registrant (Filed With SEC on November 12, 2019)

Securities Purchase Agreement, dated September 20, 2019, by and among HTG Molecular Diagnostics, Inc. and the Purchasers named therein (Filed With SEC on September 23, 2019)

Form of Pre-Funded Warrant to Purchase Shares of Common Stock (Filed With SEC on September 23, 2019)

Underwriting Agreement, dated September 20, 2019, by and among HTG Molecular Diagnostics, Inc. and Cantor Fitzgerald & Co (Filed With SEC on September 23, 2019)

Fourth Amendment to Statement of Work No. 2, dated February 15, 2019, under Master Assay Development, Commercialization and Manufacturing Agreement between the Registrant and... (Filed With SEC on May 9, 2019)

Forms of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice for Inducement Award Recipients under the HTG Molecular Diagnostics, Inc. 2014 Equity Incentive... (Filed With SEC on May 9, 2019)

Standard Forms of Stock Option Agreement, Notice of Exercise and Stock Option Grant Notice under the HTG Molecular Diagnostics, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on May 9, 2019)

HTG Molecular Diagnostics, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on May 9, 2019)

First Amendment to Amended and Restated IVD Test Development and Component Supply Agreement, dated April 23, 2019, by and between Illumina, Inc. and the Registrant (Filed With SEC on May 9, 2019)

Employment Agreement between the Company and John L. Lubniewski, dated April 1, 2019 (Filed With SEC on April 2, 2019)

Employment Agreement between the Company and Timothy B. Johnson, dated March 31, 2019 (Filed With SEC on April 2, 2019)

Sales Agreement, dated as of March 13, 2019, by and between HTG Molecular Diagnostics, Inc. and Cowen and Company, LLC (Filed With SEC on March 13, 2019)

Second Amendment to Lease Agreement (Suite 100 Administration to include Suite 200), dated January 28, 2019, by and between Pegasus Properties, L.P. and the Registrant (Filed With SEC on March 7, 2019)

HTG MOLECULAR DIAGNOSTICS, INC (53)